These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9173175)

  • 21. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases.
    Franchi A; Santucci M
    Am J Dermatopathol; 1996 Oct; 18(5):454-9. PubMed ID: 8902090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
    Lee CS; Chou ST
    Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
    Fanburg-Smith JC; Miettinen M
    Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soft tissue sarcomas in dermatology.
    Fish FS
    Dermatol Surg; 1996 Mar; 22(3):268-73. PubMed ID: 8599739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls.
    Wang J; Yang W
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():65-9. PubMed ID: 18544057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcomas arising in dermatofibrosarcoma protuberans: collision or illusion?
    Zelger B; Zelger B
    Am J Surg Pathol; 2001 Aug; 25(8):1106-8. PubMed ID: 11474302
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical fibroxanthoma: two unusual variants.
    Wilson PR; Strutton GM; Stewart MR
    J Cutan Pathol; 1989 Apr; 16(2):93-8. PubMed ID: 2474588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatofibrosarcoma protuberans with EMa+ cells. Report of a case suggesting perineurial cell differentiation.
    Zamecnik M; Michal M; Baumruk L; Mukensnabl P
    Pathol Res Pract; 2002; 198(11):767-74; discussion 775. PubMed ID: 12530581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary dermatofibrosarcoma protuberans of orbit--a rare entity.
    Rahman T; Bhattacharjee K; Sarma JD; Dey D; Kuri G
    Orbit; 2013 Apr; 32(2):127-9. PubMed ID: 23448305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bednar tumor (pigmented dermatofibrosarcoma protuberans). An analysis of six cases.
    Ding JA; Hashimoto H; Sugimoto T; Tsuneyoshi M; Enjoji M
    Acta Pathol Jpn; 1990 Oct; 40(10):744-54. PubMed ID: 2291405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pigmented dermatofibrosarcoma protuberans (Bednár tumor). An autopsy case with systemic metastasis.
    Onoda N; Tsutsumi Y; Kakudo K; Ozawa A; Niizuma K; Ohkido M; Osamura RY
    Acta Pathol Jpn; 1990 Dec; 40(12):935-40. PubMed ID: 2096596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence.
    Calonje E; Mentzel T; Fletcher CD
    Am J Surg Pathol; 1994 Jul; 18(7):668-76. PubMed ID: 8017561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatofibrosarcoma protuberans. A 10-year clinicopathological review of an uncommon tumour.
    Coard K; Branday JM; LaGrenade L
    West Indian Med J; 1994 Dec; 43(4):130-3. PubMed ID: 7900376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cathepsins in dermal fibrous tumors: an immunohistochemical study.
    Thewes M; Engst R; Boeck K; Ring J
    Eur J Dermatol; 1998 Mar; 8(2):86-9. PubMed ID: 9649659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature.
    Fletcher CD; Evans BJ; MacArtney JC; Smith N; Wilson Jones E; McKee PH
    Histopathology; 1985 Sep; 9(9):921-38. PubMed ID: 3840767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study on cutaneous histioproliferative lesions.
    Igisu K; Watanabe S
    Jpn J Clin Oncol; 1987 Dec; 17(4):343-51. PubMed ID: 2826848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifocal dermatofibrosarcoma protuberans.
    Deo KS; Sharma YK; Virmani NC; Dash KN; Chaudhari ND
    Indian J Dermatol Venereol Leprol; 2012; 78(3):385-7. PubMed ID: 22565450
    [No Abstract]   [Full Text] [Related]  

  • 39. Dermatofibrosarcoma: a rare form of soft tissue. Management and review of the literature.
    Kontzoglou K; Stamatakos M; Polyzou E; Levidou G; Iannescu R; Safioleas M
    Chirurgia (Bucur); 2011; 106(5):653-6. PubMed ID: 22165066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
    Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
    Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.